Status:
ACTIVE_NOT_RECRUITING
MIRACLE of LIFE Study
Lead Sponsor:
Mirvie
Conditions:
Preterm Labor
Preterm Birth
Eligibility:
FEMALE
18+ years
Brief Summary
The goal of this observational study is to develop and validate cell-free RNA-based biomarkers for predicting a variety of adverse pregnancy outcomes in a pregnant person population. The main question...
Detailed Description
This is a multi-center, prospective, observational cohort study, that involves the collection of blood samples from pregnant people during their second trimester of pregnancy. Maternal plasma is isola...
Eligibility Criteria
Inclusion
- Subject is willing and able to provide written informed consent.
- Subject is willing and able to provide up to 40 mL of blood via venipuncture and comply with all other study procedures.
- Subject is a pregnant female before 22 weeks of gestation
- Subject is at least 18 years of age
Exclusion
- Estimated due date (EDD) via 1st or 2nd ultrasound, date of last menstrual period (LMP), or in-vitro fertilization (IVF) implantation date is not available
- Subject is pregnant with multifetal gestation (e.g., twins)
- Subject is planning to deliver via home birth
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06074601
Start Date
August 1 2021
End Date
December 31 2025
Last Update
November 27 2024
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Diego
San Diego, California, United States, 92121
2
Women's Care Florida
Orlando, Florida, United States, 32803
3
Ochsner Health System
New Orleans, Louisiana, United States, 70115
4
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215